Classical pathway complement activation in Kawasaki syndrome

T Kohsaka1, J Abe, T Asahina

  • 1National Childrens' Hospital, Childrens' Medical Research Center, Department of Immunology, Tokyo, Japan.

Insights

Complement activation via the classical pathway occurs in Kawasaki syndrome, indicated by breakdown products. Increased production of complement components compensates for activation, maintaining normal serum levels during inflammation.

Area of Science:

  • Immunology
  • Pediatric Medicine
  • Complement System

Background:

  • Kawasaki syndrome is an acute febrile illness affecting young children.
  • The complement system plays a crucial role in innate and adaptive immunity.
  • Understanding complement activation in Kawasaki syndrome is vital for disease management.

Purpose of the Study:

  • To investigate complement activation pathways in patients with Kawasaki syndrome.
  • To examine the relationship between complement components and cytokine levels.
  • To determine if complement consumption occurs during the inflammatory process.

Main Methods:

  • Measurement of complement breakdown products (C3d, C4d, Bb, MAC) in patient plasma.
  • Assessment of hemolytic titers and intact complement protein concentrations (C3, C4, B).
  • Correlation analysis between serum cytokine levels (IL-6) and complement components.

Main Results:

  • Strong evidence of classical complement pathway activation was observed.
  • No significant decrease in hemolytic titer or intact complement proteins (C3, C4, B) was detected.
  • Elevated interleukin-6 levels correlated with C3 and B concentrations 5 days later.

Conclusions:

  • Complement activation via the classical pathway is implicated in Kawasaki syndrome.
  • Increased production of complement components accompanies the inflammatory response.
  • Activation products increase without a net decrease in serum complement levels due to compensatory production.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...